Ï㽶ÊÓƵ

New Program Launch: MI4 funding for COVID-19 research

Published: 23 March 2020

The McGill Interdisciplinary Initiative in Infection and Immunity (MI4) is pleased to announce the launch of an emergency coronavirus research fund to support nimble and effective interventions and...

McGill to partner with CCRM in commercializing regenerative medicine

Published: 10 March 2021

Ï㽶ÊÓƵ announced today it has concluded an agreement with the Centre for Commercialization of Regenerative Medicine (CCRM) to provide McGill-based startup companies with the benefit of...

Active Startup: Laurent Pharma

Published: 10 October 2019

Business Snapshot...

Pages

Back to top